Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| BONK, INC.JUPW · Entity 8011 | Director | December 30, 2022 | December 30, 2022 |
| Jupiter Wellness Acquisition Corp.JWAC · Entity 128986 | Director | February 07, 2022 | February 07, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
BONK, INC.
Report date December 30, 2022 · Filed December 30, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock options (Right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.76 | Direct | 95,000 |
Reported balance
After 2022-12-30 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-12-30 · Grant · Acquired 50,000 · Balance 95,000 F1: The options are granted under the 2022 Equity Incentive plans, with an exercise price of $0.7600 based on the closing sale price of Company's common stock on December 29, 2022. The options are exercisable within five years from the transaction date herein. |
Filing footnotes · ownership attribution and instrument terms
F1: The options are granted under the 2022 Equity Incentive plans, with an exercise price of $0.7600 based on the closing sale price of Company's common stock on December 29, 2022. The options are exercisable within five years from the transaction date herein.
Jupiter Wellness Acquisition Corp.
Report date February 07, 2022 · Filed February 07, 2022
This filing explicitly reported no securities owned.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 30, 2022 Filed Dec 30, 2022 23:12 UTC | BONK, INC. JUPW · Entity 8011 | GrantStock options (Right to buy) · Derivative | 50,000 | $0.00 Strike: $0.76 | $0.00 |
DisclosureSEC source: 0001493152-22-037196 · ownership.xml · derivative · entry 1 Torres Kaufman Nancy · CIK 0001842743 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 95,000 Underlying: Common Stock · 50,000 shares Expires not disclosed F1 · shares: The options are granted under the 2022 Equity Incentive plans, with an exercise price of $0.7600 based on the closing sale price of Company's common stock on December 29, 2022. The options are exercisable within five years from the transaction date herein. F1 · derivative.expiration_date: The options are granted under the 2022 Equity Incentive plans, with an exercise price of $0.7600 based on the closing sale price of Company's common stock on December 29, 2022. The options are exercisable within five years from the transaction date herein. Read SEC document |
| December 06, 2021 Filed Jan 28, 2022 23:09 UTC | BONK, INC. JUPW · Entity 8011 | GrantStock Options · Derivative | 25,000 | Not disclosed Strike: $1.30 | Not disclosed |
DisclosureSEC source: 0001493152-22-002600 · ownership.xml · derivative · entry 1 Torres Kaufman Nancy · CIK 0001842743 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2026-12-05 F1 · derivative.exercise_price: On December 6, 2021, and pursuant to the Issuer's 2021 Incentive Equity Plan, the Reporting Person received options to purchase up to 25,000 shares of the Issuer's common stock, par value $0.001 (the "Options"), at an exercise price of $1.30. The Options are exercisable for a period of five years and vested immediately. F1 · price: On December 6, 2021, and pursuant to the Issuer's 2021 Incentive Equity Plan, the Reporting Person received options to purchase up to 25,000 shares of the Issuer's common stock, par value $0.001 (the "Options"), at an exercise price of $1.30. The Options are exercisable for a period of five years and vested immediately. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.